News

Read our latest news, and find more about us and our portfolio companies.

2020/10/22
STORM Therapeutics selects first-in-class clinical candidate targeting METTL3

STORM Therapeutics today announces that STC-15, its first-in-class drug candidate targeting METTL3, has been selected for development towards first in human clinical studies

2020/09/25
Mosa Meat raises Series B funding to prepare for large-scale cultured meat production

Mosa Meat announced the first closing of $55M as part of a larger Series B funding round

2020/09/25
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Funds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials

2020/09/08
Rapid prototyping and validation of SARS-CoV-2 clinical diagnostic workflows

From design to prototyping, validation, and frontline diagnostic testing in nine weeks

2020/08/25
Sonde Health purchases NeuroLex Labs’ voice platform and 500K biometric samples

Sonde Health acquires NeuroLex Laboratories, Inc. to forms one of the world’s preeminent biobanks focused on vocal biomarkers

2020/07/29
DNA Script Expands Series B to $89M

Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer.

2020/07/23
Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors

Mr. Clancy brings significant strategic, financial and operational leadership experience in the biotechnology and pharmaceutical industry

2020/07/23
Synaffix Announces Third Deal Expansion by ADC Therapeutics

Synaffix B.V. announces that ADC Therapeutics SA has expanded its existing collaboration to explore additional applications, including DAR1, of Synaffix’ site-specific conjugation technologies

2020/07/08
Sonde Health Launches New Voice-Enabled Health Screening Tool to Help Employers Return to Work During the Global Pandemic

Sonde One combines 6-second voice analysis, COVID-19 questionnaire, and body temperature reading in one app

2020/06/18
Micropsi Industries Secures Two New Specialized Investors

Our Existing Backers Will Also Supply Fresh Investment

2020/06/15
Akili Announces FDA Clearance of EndeavorRx™ for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game

Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial

2020/05/20
Computers modelled on the human brain

Comment from Kai Beckmann, member, executive board, Merck KGaA

2020/05/19
Galecto Appoints New Chair and Strengthens Board of Directors

Appoints Amit Munshi as Chair, deeply experienced industry executive, CEO of Arena Pharmaceuticals

2020/04/27
Xilio Therapeutics Appoints Martin H. Huber, M.D as Chief Medical Officer

To Lead XTX201 (Tumor-Selective IL-2) and XTX101 (Tumor-Selective aCTLA-4) into the Clinic while Xilio Continues to Advance its Tumor-Selective Cytokine Pipeline

2020/04/22
Akili Announces ENDEAVORTM Digital Attention Treatment is Now Available for Children with Attention Deficit Hyperactivity Disorder (ADHD) under FDA’s COVID-19 Enforcement Discretion Guidance

ENDEAVORTM (AKL-T01) is now available for use by children with attention deficit hyperactivity disorder (ADHD) and their families

2020/04/22
FoRx Therapeutics AG Raises EUR 10 Million Seed Round

First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman

2020/04/09
Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing

Spinout Announces Investment From M Ventures, the Strategic, Corporate Venture Capital Arm of Merck KGaA, Darmstadt, Germany, to Deliver Scalable, Energy-Efficient Quantum Computing Systems

2020/02/25
Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing

2020/02/10
Artios Pharma Strengthens Clinical Development Team with Senior Appointments

Artios Pharma Limited today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development

2020/02/04
iOnctura Expands its Clinical Advisory Board

iOnctura SA announces the addition of new members to its Clinical Advisory Board (CAB)

2019/07/19
First programmable memristor computer aims to bring AI processing down from the cloud

Circuit elements that store information in their electrical resistances enable a brain-like form of computing, storing and processing information in the same place